Lisa Geng got her start as a designer, patented inventor, and creator in the fashion, toy, and film industries. The early diagnosis of her young children with special needs launched her into the world of nonprofits, pilot studies, and advocacy work.

Lisa’s experience with special needs children lead her to create the CHERAB Foundation. In addition, she was instrumental in developing IQed’s patented nutritional composition.

Lisa co-authored the peer-reviewed paper Results of a Consumer Survey on the Effectiveness of a Nutritional Blend Reported on Autism Spectrum Disorder Symptoms, Apraxia, and Other Conditions Involving Motor and Speech Delays. This study demonstrates IQed’s 92% success rate in physical and behavioral changes in adults and children with speech and motor impairments.

Lisa began her crusade in philanthropy due to the personal challenges she faced with her two young boys, now ages 22 and 24. Despite the severity of both diagnoses, her sons were mainstreamed in school and are doing fantastic today. Lisa co-authored The Late Talker, St Martin’s Press 2003, with Dr. Marilyn Agin, a neurodevelopmental pediatrician and Medical Director for NYC Early Intervention, and Malcolm Nicholl, an international journalist. Since publication, it has remained the bestselling book of its kind.

Since 2015, Lisa has served as a parent advocate on an AAN Immunization Panel. She is also a member of CUE through Cochrane US. Lisa is currently working on a second book, The Late Talker Grows Up and serves as a Late Talkers, Silent Voices executive producer. She lives on the Treasure Coast of Florida.

David Pushett, Ph.D., currently serves as Director of Global Business Development for Porsolt, a long-established preclinical CRO. For over 30 years, Porsolt has provided efficacy evaluation and safety pharmacology services. It covers the drug development process from early screening through regulatory submission.

David received a Ph.D. in genetics from Monash University (Australia) and has been involved in the biotech industry for almost two decades. This includes preclinical project management for Mindset Biopharmaceuticals, an Alzheimer’s Disease drug development company. He has over 15 years of experience in Business Development, including with MindGenix, a CRO offering preclinical services in neurology. In addition, David served as VP of Business Development at PsychoGenics, a US-based preclinical CRO. He has been instrumental in negotiating and creating deal structures for novel models and technologies.

David and his wife Sara have been members of the Cherab Foundation for years. They focus on healthy nutrition because their son Tal was also a "late talker." David devotes his career to finding answers and he hopes to continue to do so through IQed.